Telotristat Etiprate Demonstrates Clinical Benefit in Phase III Carcinoid Syndrome Study November 03, 2015Vol.38 No.10
Study: Lenvatinib-Everolimus Combination Can Improve PFS in Renal Cell Carcinoma November 03, 2015Vol.38 No.10
Phase III Trial Demonstrates Shorter, Hypofractionated RT Can Deliver Similar Results Compared to Conventional RT November 03, 2015Vol.38 No.10
Patients Receiving IMRT Had Less Toxicity Compared to 3D CRT, Study Finds November 03, 2015Vol.38 No.10
Phase III Trial Finds Equivalent OS Rates Between APBI Brachytherapy and Whole Breast Irradiation Therapy November 03, 2015Vol.38 No.10
Drugs & Targets FDA Approves Imlygic as First Oncolytic Viral Therapy in the U.S., for Melanoma November 03, 2015Vol.38 No.10
Drugs & Targets FDA Approves Varubi for Chemotherapy-Induced Nausea and Vomiting October 01, 2015Vol.38 No.09
